Philadelphia, United States
Vasowatch Inc, founded in 2021, is revolutionizing obstetric care by enhancing safety during childbirth through its innovative technology in the Health Care and Medical Devices industries. Headquartered in the United States, Vasowatch is on a mission to address the leading cause of postpartum hemorrhage—uterine muscle exhaustion—by offering a real-time alert system based on streaming maternal heart rate data.
The company’s solution aims to reduce hemorrhage incidents by 60%, potentially saving $1B in annual obstetrics costs. The effectiveness of this technology makes it a critical asset for global healthcare systems seeking to improve maternal outcomes.
In a recent financial milestone, Vasowatch secured a $100.00K Seed Round investment on 31 December 2023, with backing from TechRise Chicago. As Vasowatch looks to scale its life-saving technology, it presents a compelling opportunity for investors targeting impactful healthcare innovations.
